High-Quality CAR-T Treatment for Acute Lymphoblastic Leukemia - Miltenyi Suppliers
T&L Biotechnology Co., Ltd. is at the forefront of revolutionary cancer therapies, notably with its CAR-T treatment tailored for Acute Lymphoblastic Leukemia (ALL). This innovative approach harnesses the power of the body’s own immune system to actively target and eliminate leukemia cells. By modifying a patient’s T Cells to express chimeric antigen receptors, our CAR-T therapy enables these immune cells to recognize and destroy malignant cells with precision
- Heterophilic Antibodies Service
- Custom Optimizing Car-T Potency
- High-Quality Gene Editing Tools
- High-Quality Regulatory Support
- Sickle Cell Therapies Suppliers
- Biopharmaceutical Cdmo Supplier
- Custom Exosome Therapy Pipeline
- Custom Fluorescence Microscopes
- High-Quality Bioreactor For Cgt
- Gene Therapy Production Service